MSGP — Medsmart Income Statement
0.000.00%
FinancialsHighly SpeculativeMicro Cap
- $0.00m
- $1.19m
- $0.54m
Annual income statement for Medsmart, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2009 December 31st | 2010 December 31st | R2011 December 31st | 2012 December 31st | 2013 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | — | USG | — | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.02 | 0.001 | 0.027 | 0.048 | 0.542 |
Cost of Revenue | |||||
Gross Profit | 0.016 | 0.001 | 0.012 | 0.021 | 0.268 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 0.106 | 0.291 | 0.418 | 0.669 | 0.814 |
Operating Profit | -0.086 | -0.29 | -0.391 | -0.621 | -0.273 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.005 | -4.37 | -0.917 | -9.95 | 2.67 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.005 | -4.37 | -0.917 | -9.95 | 2.67 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.005 | -4.37 | -0.917 | -9.95 | 2.67 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.005 | -4.37 | -0.917 | -9.95 | 2.67 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -14.3 | -3,178 | -369 | -197 | 8.53 |
Dividends per Share |